Results 41 to 50 of about 369 (144)

DEVELOPMENT AND VALIDATION OF METHODS FOR QUANTITATIVE DETERMINATION OF TOFIZOPAM AND FENAZEPAM IN TABLETS METHOD OF HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

open access: yesКубанский научный медицинский вестник, 2017
Developed optimal conditions of quantitative analysis of tablets "Grandaxinum" and tablets "Fenazepam", using the method high-performance liquid chromatography.
A. M. LAZITSKAYA   +2 more
doaj   +1 more source

Fatal accidental asphyxia in the reverse jack-knife position on a chair with wheels [PDF]

open access: yes, 2019
Accidental death from postural or positional asphyxia can occur when an individual’s body compromises their respiration. The diagnosis of positional asphyxia is usually based on circumstantial evidence supported by the absence of other significant ...
Waters, Brian   +26 more
core   +1 more source

Prediction of Drug Indications Based on Chemical Interactions and Chemical Similarities

open access: yesBioMed Research International, Volume 2015, Issue 1, 2015., 2015
Discovering potential indications of novel or approved drugs is a key step in drug development. Previous computational approaches could be categorized into disease‐centric and drug‐centric based on the starting point of the issues or small‐scaled application and large‐scale application according to the diversity of the datasets.
Guohua Huang   +5 more
wiley   +1 more source

Antidepressant Prophylaxis Reduces Depression Risk but Does Not Improve Sustained Virological Response in Hepatitis C Patients Receiving Interferon Without Depression at Baseline: A Systematic Review and Meta‐Analysis

open access: yesCanadian Journal of Gastroenterology and Hepatology, Volume 27, Issue 10, Page 575-581, 2013., 2013
BACKGROUND: Depression complicates interferon‐based hepatitis C virus (HCV) antiviral therapy in 10% to 40% of cases, and diminishes patient well‐being and ability to complete a full course of therapy. As a consequence, the likelihood of achieving a sustained virological response (SVR [ie, permanent viral eradication]) is reduced.
Awad Al-Omari   +3 more
wiley   +1 more source

Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome

open access: yesGastroenterology Research and Practice, Volume 2012, Issue 1, 2012., 2012
Irritable bowel syndrome (IBS) accounts for 25% of gastroenterology output practice, making it one of the most common disorders in this practice. Psychological and social factors may affect the development of this chronic disorder. Furthermore, psychiatric symptoms and psychiatric diseases are highly prevalent in this condition, but the approach to ...
Emanuele Sinagra   +3 more
wiley   +1 more source

Tofisopam, a new 2,3-benzodiazepine. Inhibition of changes induced by stress loading and hypothalamic stimulation

open access: yes, 1983
Effects of tofisopam, a new 2,3-benzodiazepine compound, were investigated on the following: gastric ulceration, induced by water-immersion stress in normal rats and by immobilization stress in olfactory-bulbectomized (OB) rats; and propulsion of the ...
K. Yamaguchi   +5 more
core   +1 more source

Expanding the Scope of 1,2‐Diazepines Through Alternative Activation Strategies

open access: yesEuropean Journal of Organic Chemistry, Volume 29, Issue 35, 19 September 2026.
Often overlooked due to tedious synthetic routes, 1,2‐diazepines can be found in handful of biorelevant molecules. Previous reports from our group lifted the principal synthetic lock: a rapid and user‐friendly protocol to reach monocyclic 1,2‐diazepines from readily available pyridines and electrophilic activating groups. Herein, we extend the scope of
Alexis Leblais   +4 more
wiley   +1 more source

Persistent Visual Aura following Catheter Ablation in a Patient with WPW Syndrome

open access: yesBehavioural Neurology, Volume 18, Issue 3, Page 187-192, 2007., 2007
We report a patient who has had persistent visual disturbances since she underwent catheter ablation to treat her Wolff‐Parkinson‐White (WPW) syndrome. We examined her visual symptoms carefully and quantitatively by means of our newly developed method combining image‐processing and psychophysics.
Shinichi Koyama, Mitsuru Kawamura
wiley   +1 more source

Clinical studies on tofisopam in patients with lower urinary tract symptoms [PDF]

open access: yes, 1989
The clinical effects of tofisopam were studied on 29 patients with lower urinary tract symptoms. Tofisopam was administered at a dose of 50 mg three times a day for more than 2 weeks.
笹川, 五十次
core  

Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam

open access: yesEuropean Journal of Clinical Pharmacology, 2007
Mária Tóth   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy